Table 2. Primary lung surgery combined adjuvant treatment and postoperative outcomes.
| Variable | Total (n=88) |
|---|---|
| Pulmonary resection, n (%) | |
| Sublobar resection | 5 (5.7) |
| Lobectomy | 60 (68.2) |
| Pneumonectomy | 23 (26.1) |
| Pulmonary margin, n (%) | |
| R0 | 86 (97.7) |
| R1 | 2 (2.3) |
| Adjuvant therapy, n (%) | |
| Chemotherapy | 31 (35.2) |
| TKI or TKI + chemotherapy† | 31 (35.2) |
| No treatment | 10 (11.4) |
| Unknown‡ | 16 (18.2) |
| Postoperative complications, n (%) | 8 (9.1) |
| Respiratory failure | 2 (2.3) |
| Bronchial fistula | 2 (2.3) |
| Atelectasis + respiratory failure | 1 (1.1) |
| Air leakage | 1 (1.1) |
| Chylothorax | 1 (1.1) |
| Pulmonary embolism | 1 (1.1) |
| Postoperative mortality at 30 days, n (%) | 1 (1.1) |
†, 31 cases with EGFR mutant; ‡, no adjuvant therapy data of 5 case with EGFR mutation, 1 case with ALK rearrangements and 1 case with ROS1 rearrangements. TKI, tyrosine-kinase inhibitor; SCC, squamous cell carcinoma.